Florida Patent of the Month – March 2024

Bazelet Health Systems, Inc. has unveiled a groundbreaking invention in the realm of cannabinoid research that aims to revolutionize therapeutic approaches. Their latest invention, a novel capsule formulation, encapsulates the power of cannabigerol (CBG) alongside palmitoylethanolamide (PEA), piperine, and curcumin, presenting a unique synergy for enhanced oral absorption and efficacy.

Bazelet Health Systems was inspired by the broad range of uses afforded by cannabis. They view this plant as one of the most valuable on earth thanks to its potential to transform food, medicine, beauty, genetics, health and so on. Their recently patented composition, marketed as Cannabis-ZERO™ provides the world with access to legal, non-psychoactive cannabis products.

At the heart of this innovation lies the potent combination of CBG, a cannabinoid known for its diverse pharmacological properties, and PEA, a fatty acid amide with anti-inflammatory and neuroprotective effects. By harnessing the potential of these two compounds, Bazelet Health Systems aims to unlock new avenues for addressing various health conditions.

The inclusion of piperine and curcumin further amplifies the therapeutic impact of the capsule. Piperine, derived from black pepper, is renowned for its ability to enhance the bioavailability of nutrients and pharmaceuticals. Curcumin, extracted from turmeric, boasts anti-inflammatory, antioxidant, and neuroprotective properties, complementing the holistic approach of the formulation.

This innovative capsule represents a significant milestone in cannabinoid research, offering a safe, effective, and versatile solution for a wide range of health issues. With its carefully curated blend of natural ingredients, it holds promise for conditions such as chronic pain, inflammation, neurological disorders, and more.

Moreover, the absence of tetrahydrocannabinol (THC) and cannabidiol (CBD) in the formulation ensures a non-psychoactive experience, making it suitable for individuals seeking therapeutic benefits without unwanted side effects.

Bazelet Health Systems’ dedication to research and development is evident in this novel invention. By pushing the boundaries of cannabinoid science, they strive to empower individuals worldwide with innovative solutions for better health and well-being.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Recent Posts